GO:0030171 voltage-gated proton channel activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030171 defines the molecular function of voltage-gated proton channels, which mediate proton (H+) flux across membranes in a voltage-dependent manner.
• The founding member is HVCN1 (Hv1) in humans, but the family has recently expanded with the discovery of HCNL1 and related proteins in diverse organisms.
• Hv1 is highly expressed in immune cells, where it supports reactive oxygen species production by compensating charge during NADPH oxidase activity.
• Voltage-gated proton channels are implicated in cancer, neurodegeneration, and inflammation, making them emerging drug targets [7,8].
• Their activity is modulated by temperature, zinc, and small-molecule inhibitors, offering multiple angles for experimental perturbation [1,2,4].
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect the physiological roles of Hv1 and its homologs.
Description
Voltage-gated proton channel activity (GO:0030171) is a molecular function that enables the selective, voltage-dependent transfer of protons across cellular membranes. This activity is fundamental to many physiological processes, including pH homeostasis, reactive oxygen species (ROS) production, and cell migration. The best-characterized protein exhibiting this activity is the human voltage-gated proton channel Hv1, encoded by the HVCN1 gene. Recent studies have revealed an unexpected expansion of the voltage-gated proton channel family, with new members identified in various species, suggesting broader roles than previously appreciated. Understanding this activity is critical for researchers in immunology, neuroscience, and oncology, as it links proton flux to cellular signaling and disease [5,7]. The channel's unique properties, such as extreme proton selectivity and voltage dependence, make it a fascinating subject for biophysical and pharmacological studies [6,8].
voltage-gated proton channel activity At A Glance
| GO ID | GO:0030171 |
|---|---|
| GO term | voltage-gated proton channel activity |
| Ontology | molecular_function |
| Synonym | voltage-dependent proton channel activity, voltage gated proton channel activity |
| Major function | Enables voltage-dependent transmembrane proton transfer |
| Defining protein | HVCN1 (Hv1) in humans; homologs in other species |
| Key regulators | Membrane potential, pH gradient, temperature, zinc [1,2] |
| Associated diseases | Cancer, neurodegeneration, immune disorders [5,7] |
What Is GO:0030171?
According to the Gene Ontology, GO:0030171 describes the ability to facilitate the transmembrane movement of protons through a channel whose opening is controlled by the voltage difference across the membrane. In other words, it is the molecular function of a protein that forms a proton-selective pore and opens or closes in response to changes in membrane potential, allowing protons to flow down their electrochemical gradient. This activity is distinct from other proton transport mechanisms because it is both voltage-gated and highly selective for protons over other ions.
Why Is voltage-gated proton channel activity Important in Cell Biology?
Voltage-gated proton channel activity is crucial for a wide range of biological processes, from immune defense to neuronal function. In phagocytes, Hv1-mediated proton efflux sustains NADPH oxidase activity and ROS production, which are essential for pathogen killing. In the nervous system, Hv1 in microglia contributes to neuroinflammation and secondary damage after spinal cord injury. Moreover, Hv1 is overexpressed in many cancers, where it promotes an acidic tumor microenvironment and supports cell proliferation and migration. Thus, understanding this activity provides insights into fundamental physiology and offers therapeutic opportunities for inflammatory diseases, cancer, and neurological disorders.
• Supports ROS production in immune cells by compensating for electron transfer in NADPH oxidase.
• Regulates intracellular pH in various cell types, influencing enzyme activity and cell cycle progression.
• Facilitates sperm capacitation and fertilization in some species.
• Contributes to microglial activation and neuroinflammation after spinal cord injury.
• Promotes cancer cell proliferation, migration, and invasion through pH regulation.
• Serves as a target for small-molecule inhibitors with anticancer potential [7,8].
• Exhibits temperature sensitivity, linking proton flux to thermal responses.
• Is inhibited by zinc, suggesting a role in metal homeostasis.
• Shows expanded family members with potential novel functions.
• Provides a model system for studying voltage sensing and proton selectivity.
Molecular Mechanism of voltage-gated proton channel activity
Voltage Sensing and Channel Gating
In simple terms: The channel opens when the membrane voltage changes, like a door that unlocks with an electric signal.
Voltage-gated proton channels open in response to membrane depolarization, a process driven by the movement of charged residues within the voltage-sensing domain. This domain is homologous to that of other voltage-gated ion channels but lacks a canonical pore domain; instead, the proton permeation pathway is formed by the voltage-sensing domain itself. The precise mechanism of voltage sensing involves arginine residues that move upon changes in membrane potential, triggering conformational changes that open the proton conduction pathway.
Proton Selectivity and Conduction
In simple terms: The channel is extremely picky, allowing only protons to pass while blocking other ions.
Voltage-gated proton channels exhibit remarkable selectivity for protons over other cations, with a selectivity ratio that can exceed 10^6. This selectivity is achieved through a narrow constriction in the pore that excludes larger ions and a network of hydrogen-bonded water molecules and acidic residues that facilitate proton hopping. The conduction mechanism likely involves protonation and deprotonation of key residues, allowing protons to move rapidly through the channel.
Regulation by pH and Temperature
In simple terms: The channel's activity is fine-tuned by the acidity inside the cell and by temperature.
The activity of voltage-gated proton channels is strongly modulated by the pH gradient across the membrane; intracellular acidification shifts the voltage dependence of activation to more negative potentials, promoting channel opening. Additionally, temperature affects the gating kinetics of Hv1, with higher temperatures accelerating activation and altering the voltage dependence. This temperature sensitivity may have physiological implications for processes such as inflammation and fever.
Pharmacological Modulation
In simple terms: Drugs can block or modify the channel's activity, which is useful for therapy and research.
Several small-molecule inhibitors of Hv1 have been developed, including 5-phenyl-2-aminoimidazoles with anticancer potential. Zinc ions also inhibit Hv1, likely by binding to a site in the voltage-sensing domain and stabilizing the closed state. These modulators serve as valuable tools to probe channel function and as leads for drug development.
Diversity of Voltage-Gated Proton Channels
In simple terms: There are more types of these channels than we thought, with new ones recently discovered.
The voltage-gated proton channel family has recently expanded with the identification of HCNL1 and other homologs in various organisms. These new members exhibit distinct biophysical properties and may have specialized functions. Their discovery challenges previous assumptions about the uniqueness of Hv1 and opens new avenues for research.
Key Genes Involved in GO:0030171 voltage-gated proton channel activity
The following genes encode proteins that exhibit or regulate voltage-gated proton channel activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HVCN1 | Encodes the human voltage-gated proton channel Hv1 | Primary model for studying GO:0030171; knockout mice available |
| HCNL1 | Recently identified voltage-gated proton channel | Expands the family; zinc inhibits its activity [2,3] |
| NOX2 (CYBB) | NADPH oxidase subunit that produces superoxide | Functional partner of Hv1 in phagocytes; Hv1 compensates charge |
| NOX1 | NADPH oxidase subunit in non-phagocytic cells | May couple with Hv1 in cancer cells |
| NOX4 | NADPH oxidase subunit | Potential interaction with Hv1 in various tissues |
| NOX5 | Calcium-dependent NADPH oxidase | May require Hv1 for optimal activity |
| RAC1 | Small GTPase regulating NADPH oxidase | Upstream regulator of ROS production involving Hv1 |
| RAC2 | Small GTPase in phagocytes | Regulates NOX2 and Hv1-dependent ROS |
| PTPRC (CD45) | Protein tyrosine phosphatase | May regulate Hv1 phosphorylation |
| SRC | Tyrosine kinase | Potential modulator of Hv1 via phosphorylation |
| PKC | Protein kinase C | Phosphorylates Hv1 and regulates its activity |
| CAV1 | Caveolin-1 | May localize Hv1 to membrane microdomains |
| ACTN1 | Actinin-1 | Cytoskeletal protein potentially interacting with Hv1 |
| TNF | Tumor necrosis factor | Inflammatory cytokine that may induce Hv1 expression |
| IL1B | Interleukin-1 beta | Pro-inflammatory cytokine linked to Hv1 in microglia |
| CXCL12 | Chemokine | May promote Hv1-dependent cell migration |
| MMP9 | Matrix metalloproteinase-9 | Secreted in response to Hv1-mediated pH changes |
| VEGFA | Vascular endothelial growth factor A | Angiogenesis factor potentially regulated by Hv1 |
How Is voltage-gated proton channel activity Regulated?
Voltage-gated proton channel activity is regulated at multiple levels. The channel's opening is directly controlled by membrane potential and pH gradients, with intracellular acidification promoting activation. Phosphorylation by protein kinase C (PKC) modulates Hv1 activity, and other kinases such as Src may also play a role. Zinc ions inhibit Hv1 by binding to the voltage-sensing domain. Temperature affects gating kinetics, with higher temperatures accelerating activation. Additionally, the expression of HVCN1 is regulated by inflammatory cytokines such as TNF and IL-1β in microglia. These regulatory mechanisms ensure that proton flux is tightly coupled to cellular needs.
voltage-gated proton channel activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HVCN1 | Cancer (breast, colon, prostate) | Knockout and overexpression in cancer cell lines |
| HVCN1 | Neuroinflammation after spinal cord injury | Microglia-specific knockout mice |
| HVCN1 | Chronic granulomatous disease | Patient-derived macrophages with HVCN1 mutations |
| HCNL1 | Zinc-related disorders | Zinc-sensitive knock-in models |
| HVCN1 | Inflammatory diseases | Cytokine-stimulated immune cells |
Voltage-gated proton channels in cancer
Hv1 is overexpressed in many cancer types, including breast, colon, and prostate cancer, where it contributes to an acidic tumor microenvironment that promotes invasion and metastasis. Inhibitors of Hv1, such as 5-phenyl-2-aminoimidazoles, show anticancer potential in preclinical models. Targeting Hv1 may therefore represent a novel therapeutic strategy for solid tumors.
Voltage-gated proton channels in neuroinflammation and neurodegeneration
In the central nervous system, Hv1 is expressed in microglia and contributes to neuroinflammation after spinal cord injury. Microglial Hv1 promotes ROS production and pro-inflammatory cytokine release, exacerbating secondary damage. Inhibition or knockout of Hv1 reduces neuroinflammation and improves functional recovery in animal models, suggesting a therapeutic target for neurodegenerative conditions.
Voltage-gated proton channels in immune disorders
Hv1 is critical for the respiratory burst in phagocytes, and its dysfunction leads to impaired pathogen killing. Conversely, excessive Hv1 activity may contribute to autoimmune and inflammatory diseases. Modulating Hv1 activity could thus be beneficial in conditions such as chronic granulomatous disease or inflammatory bowel disease.
From voltage-gated proton channel activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of Hv1 in ROS production? | HVCN1 knockout mice or phagocytes |
| How does zinc inhibit Hv1? | Point mutations in the zinc-binding site of HVCN1 |
| Does Hv1 contribute to cancer progression? | Xenograft models with HVCN1 overexpression or knockout |
| What is the effect of temperature on Hv1 gating? | Temperature-controlled patch-clamp on HVCN1-expressing cells |
| Can Hv1 be targeted by drugs? | Pharmacological inhibition in cell-based assays |
| What are the functions of HCNL1? | Knockout and knock-in models for HCNL1 |
How to Study the voltage-gated proton channel activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp | Proton currents and gating | Biophysical characterization of Hv1 |
| pH imaging | Intra/extracellular pH changes | Live-cell pH regulation |
| CRISPR knockout | Loss of gene function | Phenotypic analysis of HVCN1 |
| CRISPR knock-in | Tagged or mutant protein expression | Localization and function studies |
| Overexpression | Gain of function | Cancer and signaling studies |
| RNA-seq | Transcriptional changes | Pathway analysis after Hv1 modulation |
| Proteomics | Protein interactions | Identifying Hv1 binding partners |
| High-throughput screening | Drug discovery | Identifying Hv1 modulators |
Electrophysiology
Patch-clamp electrophysiology is the gold standard for measuring voltage-gated proton channel activity. It allows real-time recording of proton currents in response to voltage steps and pH changes. This method can be used to study gating kinetics, voltage dependence, and pharmacology of Hv1 and its homologs [1,2].
Fluorescence-based pH imaging
Genetically encoded pH sensors or chemical dyes can monitor intracellular and extracellular pH changes driven by Hv1 activity. This approach is useful in live cells and tissues to assess the contribution of Hv1 to pH homeostasis and ROS production.
Molecular biology and CRISPR screens
CRISPR-Cas9 knockout, knock-in, and overexpression models enable loss- and gain-of-function studies of HVCN1 and related genes. High-throughput CRISPR screens can identify modifiers of Hv1 activity or its downstream effects.
Pharmacological profiling
Small-molecule inhibitors and activators of Hv1 can be tested using electrophysiology, pH imaging, and cell-based assays [7,8]. Zinc and other metal ions can also be used to probe channel function.
How CRISPR Can Be Used to Study GO:0030171 voltage-gated proton channel activity
Knockout
CRISPR-Cas9 knockout of HVCN1 or HCNL1 is used to abolish voltage-gated proton channel activity and study its physiological consequences. Knockout models have revealed roles in ROS production, immune function, and neuroinflammation [5,6].
Point Mutation
Point mutations can be introduced into HVCN1 to dissect the molecular determinants of voltage sensing, proton selectivity, and drug binding [2,6]. For example, mutations in the zinc-binding site can abolish zinc inhibition.
Knock-in
Knock-in of tagged or reporter versions of HVCN1 allows visualization and tracking of the channel in live cells. This approach can also be used to express disease-associated mutants.
Overexpression
Overexpression of HVCN1 in cell lines or animal models is used to study gain-of-function effects, such as enhanced ROS production, pH regulation, and tumorigenesis. Overexpression systems are also valuable for drug screening.
How EDITGENE Supports voltage-gated proton channel activity Research
Researchers studying voltage-gated proton channel activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as ROS production, pH regulation, or tumor growth. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models, enabling rigorous functional studies of GO:0030171 and its associated genes.
Contact EDITGENE today to design your custom CRISPR model for voltage-gated proton channel activity research.
Frequently Asked Questions About voltage-gated proton channel activity
What is voltage-gated proton channel activity?
It is a molecular function (GO:0030171) that enables protons to cross membranes through a channel that opens in response to voltage changes.
What genes are involved in voltage-gated proton channel activity?
The primary gene is HVCN1, which encodes Hv1; recently, HCNL1 and other homologs have been identified [3,6].
What diseases are associated with voltage-gated proton channels?
They are implicated in cancer, neuroinflammation, and immune disorders [5,7].
How is voltage-gated proton channel activity regulated?
It is regulated by membrane potential, pH, temperature, zinc, and phosphorylation [1,2,6].
What methods are used to study voltage-gated proton channels?
Patch-clamp electrophysiology, pH imaging, CRISPR screens, and pharmacological profiling are common methods [6,7].
Can voltage-gated proton channels be targeted by drugs?
Yes, small-molecule inhibitors such as 5-phenyl-2-aminoimidazoles are being developed for cancer therapy [7,8].
What is the role of Hv1 in the immune system?
Hv1 supports ROS production in phagocytes by compensating charge during NADPH oxidase activity.
How does zinc affect voltage-gated proton channels?
Zinc inhibits Hv1 by binding to the voltage-sensing domain.
What is the evolutionary significance of voltage-gated proton channels?
The recent expansion of the family suggests they are more widespread and diverse than previously thought.
How can CRISPR help study voltage-gated proton channels?
CRISPR knockout, knock-in, and overexpression models allow precise manipulation of HVCN1 and related genes to study their functions.
Conclusion
Voltage-gated proton channel activity (GO:0030171) is a fundamental molecular function with critical roles in immunity, pH regulation, and cancer. The recent discovery of new family members and the development of pharmacological modulators highlight the growing importance of this field. CRISPR-based models are indispensable for dissecting the mechanisms and physiological relevance of these channels. EDITGENE's comprehensive services empower researchers to create tailored cell models and accelerate discoveries in this exciting area.
References
- 1. Fujiwara Y. 2024. Temperature Dependent Activity of the Voltage-Gated Proton Channel.. Adv Exp Med Biol 1461:109-125 PMID: 39289277
- 2. Kuwabara MF et al.. 2024. Zinc inhibits the voltage-gated proton channel HCNL1.. Biophys J 123(24):4256-4265 PMID: 39210595
- 3. Chaves G et al.. 2023. Unexpected expansion of the voltage-gated proton channel family.. FEBS J 290(4):1008-1026 PMID: 36062330
- 4. Korpos É et al.. 2023. New 'kids' on the voltage-gated proton channel block.. FEBS J 290(4):970-973 PMID: 36315610
- 5. Zheng J et al.. 2022. Microglial voltage-gated proton channel Hv1 in spinal cord injury.. Neural Regen Res 17(6):1183-1189 PMID: 34782552
- 6. Decoursey TE. 2012. Voltage-gated proton channels.. Compr Physiol 2(2):1355-85 PMID: 23798303
- 7. Piga M et al.. 2025. Targeting voltage-gated proton channel H(V)1: Optimised 5-phenyl-2-aminoimidazoles with anticancer potential.. Eur J Med Chem 297:117936 PMID: 40663975
- 8. Borrego J et al.. 2025. Modulators of the Human Voltage-Gated Proton Channel H(v)1.. Pharmaceuticals (Basel) 18(10) PMID: 41155595
